Researchers found increased odds for clinical remission on dupilumab with high blood eosinophil and fractional exhaled nitric ...

For the adolescents at baseline, 54.9% of girls and 60.4% of boys were under the 50th percentile for height, while 73.2% and ...

SAN DIEGO — Adolescents and adults with eosinophilic esophagitis improved with dupilumab regardless of whether they were practicing food elimination diets during treatment, according to a poster ...

1 Dupilumab is being jointly developed by Regeneron ... allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious ...

Dupilumab has been accepted for priority review by the US Food and Drug Administration (FDA) for the treatment of bullous pemphigoid (BP) in adults, according to a press release from the ...

The FDA has approved these four biologics to treat atopic dermatitis: dupilumab, lebrikizumab, nemolizumab, and tralokinumab. They are all types of biologics called monoclonal antibodies.

for Dupixent ® (dupilumab) to treat adults with bullous pemphigoid (BP). The sBLA is supported by data from a pivotal trial evaluating the efficacy and safety of Dupixent in 106 adults with ...

1 Dupilumab is being jointly developed by Regeneron ... allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious ...

1 Dupilumab is being jointly developed by Regeneron and Sanofi ... Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, ...